A study for a 32 year old woman who takes Clonazepam, Wellbutrin - from FDA reports


Summary

665 females aged 32 (±5) who take the same drugs are studied. This is a personalized study for a 32 year old female patient who has Depression, Anxiety Disorder. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Oct, 19, 2017

665 females aged 32 (±5) who take Clonazepam, Wellbutrin are studied.


Number of reports submitted per year:

Clonazepam, Wellbutrin for a 32-year old woman.

Information of the patient in this study:

  • Age: 32
  • Gender: female
  • Conditions: Depression, Anxiety Disorder
  • Drugs taken:
    • Clonazepam (clonazepam)
    • Wellbutrin (bupropion hydrochloride)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  • drug ineffective
  • international normalised ratio decreased
  • nausea and vomiting
  • blood test abnormal
  • dizziness
  • diarrhea
  • hallucinations
  • malaise
  • pain
  • convulsion
1 - 6 months:
  • insomnia
  • suicidal ideation
  • fatigue
  • drug ineffective
  • memory loss
  • grand mal convulsion
  • seizures
  • pain
  • pulmonary embolism
  • itching
6 - 12 months:
  • type 2 diabetes
  • gastric ulcer
  • hysterectomy
  • inflammation
  • back pain
  • bacterial infection
  • bladder disorder
  • fungal infection
  • nausea
  • multiple allergies
1 - 2 years:
  • gastric ulcer
  • type 2 diabetes
  • nausea
  • multiple allergies
  • vulvovaginal candidiasis
  • back pain
  • joint pain
  • bacterial infection
  • bladder disorder
  • muscle spasms
2 - 5 years:
  • type 2 diabetes
  • gastric ulcer
  • bacterial infection
  • hysterectomy
  • fungal infection
  • inflammation
  • bladder disorder
  • protein - urine
  • diabetic eye disease
  • deep venous thrombosis
5 - 10 years:
  • pulmonary embolism
  • deep venous thrombosis
  • oedema peripheral
  • mental disorder
  • pain
  • pain in extremity
  • subclavian vein thrombosis
  • transient ischaemic attack
  • jugular vein thrombosis
  • speech impairment (adult)
10+ years:
  • fall
  • wrist fracture
  • hand fracture
  • nausea
not specified:
  • nausea
  • completed suicide
  • pain
  • weight increased
  • drug ineffective
  • diabetes
  • dizziness
  • insomnia
  • type 2 diabetes
  • fatigue

Top conditions involved for these people *:

  • Bipolar Disorder (84 people, 12.63%)
  • Pain (56 people, 8.42%)
  • Insomnia (39 people, 5.86%)
  • Birth Control (32 people, 4.81%)
  • Sleep Disorder (26 people, 3.91%)

Top co-used drugs for these people *:

  • Seroquel (114 people, 17.14%)
  • Lamictal (100 people, 15.04%)
  • Abilify (76 people, 11.43%)
  • Topamax (65 people, 9.77%)
  • Effexor (62 people, 9.32%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Clonazepam, Anxiety disorder, Depression, Wellbutrin

You may be interested in these reviews

More reviews for: Clonazepam, Anxiety disorder, Depression, Wellbutrin